Aktionsplan BioMarin Pharmaceutical
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen BioMarin Pharmaceutical
BioMarin Pharmaceutical Inc. — американская биотехнологическая компания со штаб-квартирой в Сан-Рафаэле, Калифорния . У него есть офисы и помещения в США , Южной Америке , Азии и Европе . Основным направлением деятельности и исследованиями BioMarin является заместительная терапия ферментами (ФЗТ). weitere detailsIPO date | 1999-07-23 |
---|---|
ISIN | US09061G1013 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.biomarin.com |
Цена ао | 65.86 |
Preisänderung pro Tag: | 0% (65.86) |
---|---|
Preisänderung pro Woche: | +2.36% (64.34) |
Preisänderung pro Monat: | +3.21% (63.81) |
Preisänderung über 3 Monate: | +0.3963% (65.6) |
Preisänderung über sechs Monate: | -29% (92.76) |
Preisänderung pro Jahr: | -25.41% (88.3) |
Preisänderung über 3 Jahre: | -16.65% (79.02) |
Preisänderung über 5 Jahre: | -15.73% (78.15) |
Preisänderung über 10 Jahre: | -30.05% (94.15) |
Preisänderung seit Jahresbeginn: | -0.6187% (66.27) |
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
Transaktionsdatum | Offenlegungsdatum | Insider | Typ | Preis | Volumen | Menge | Teilen bis zu, % | Danach teilen, % | Dokumentieren |
---|---|---|---|---|---|---|---|---|---|
12.11.2024 | 12.11.2024 | Guyer Charles Greg Officer |
Kaufen | 66.37 | 350 301 | 5278 | 0 | 0 | Link |
10.05.2024 | 13.05.2024 | BIENAIME JEAN JACQUES Director |
Verkauf | 81.14 | 1 622 800 | 20000 | 0 | -0.01 | Link |
10.05.2024 | 13.05.2024 | BIENAIME JEAN JACQUES Director |
Kaufen | 63.1 | 1 262 000 | 20000 | 0 | 0.01 | Link |
09.05.2024 | 13.05.2024 | BIENAIME JEAN JACQUES Director |
Verkauf | 81.62 | 1 632 400 | 20000 | 0 | -0.01 | Link |
09.05.2024 | 13.05.2024 | BIENAIME JEAN JACQUES Director |
Kaufen | 63.1 | 1 262 000 | 20000 | 0 | 0.01 | Link |
12.04.2024 | 15.04.2024 | BIENAIME JEAN JACQUES Director |
Verkauf | 91.26 | 1 825 200 | 20000 | 0 | -0.01 | Link |
12.04.2024 | 15.04.2024 | BIENAIME JEAN JACQUES Director |
Kaufen | 63.1 | 1 262 000 | 20000 | 0 | 0.01 | Link |
11.04.2024 | 15.04.2024 | BIENAIME JEAN JACQUES Director |
Verkauf | 90.99 | 1 819 800 | 20000 | 0 | -0.01 | Link |
11.04.2024 | 15.04.2024 | BIENAIME JEAN JACQUES Director |
Kaufen | 63.1 | 1 262 000 | 20000 | 0 | 0.01 | Link |
10.04.2024 | 12.04.2024 | Burkhart Erin GVP, Chief Accounting Officer |
Verkauf | 90 | 205 740 | 2286 | 0 | 0 | Link |
10.01.2024 | 11.01.2024 | BIENAIME JEAN JACQUES Director |
Verkauf | 96.38 | 963 800 | 10000 | 0 | -0.01 | Link |
10.01.2024 | 11.01.2024 | BIENAIME JEAN JACQUES Director |
Kaufen | 63.1 | 631 000 | 10000 | 0 | 0.01 | Link |
09.01.2024 | 11.01.2024 | BIENAIME JEAN JACQUES Director |
Verkauf | 98.19 | 981 900 | 10000 | 0 | -0.01 | Link |
09.01.2024 | 11.01.2024 | BIENAIME JEAN JACQUES Director |
Kaufen | 63.1 | 631 000 | 10000 | 0 | 0.01 | Link |
13.12.2023 | 14.12.2023 | Davis George Eric EVP, Chief Legal Officer |
Verkauf | 95.3 | 1 311 710 | 13764 | 0 | -0.01 | Link |
08.08.2023 | 09.08.2023 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 88.29 | 529 740 | 6000 | 0 | 0 | Link |
08.08.2023 | 09.08.2023 | Davis George Eric EVP, Chief Legal Officer |
Verkauf | 89.42 | 983 620 | 11000 | 0 | -0.01 | Link |
07.08.2023 | 09.08.2023 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 88.1 | 352 400 | 4000 | 0 | 0 | Link |
10.05.2023 | 11.05.2023 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 94.85 | 2 845 500 | 30000 | 0 | -0.02 | Link |
10.05.2023 | 11.05.2023 | BIENAIME JEAN JACQUES Chief Executive Officer |
Kaufen | 67.81 | 2 034 300 | 30000 | 0 | 0.02 | Link |
09.05.2023 | 11.05.2023 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 94.93 | 2 847 900 | 30000 | 0 | -0.02 | Link |
09.05.2023 | 11.05.2023 | BIENAIME JEAN JACQUES Chief Executive Officer |
Kaufen | 67.81 | 2 034 300 | 30000 | 0 | 0.02 | Link |
06.04.2023 | 10.04.2023 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 96.13 | 961 300 | 10000 | 0 | -0.01 | Link |
06.04.2023 | 10.04.2023 | BIENAIME JEAN JACQUES Chief Executive Officer |
Kaufen | 67.81 | 678 100 | 10000 | 0 | 0.01 | Link |
25.01.2023 | 27.01.2023 | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
Verkauf | 115.7 | 5 669 300 | 49000 | 0 | -0.03 | Link |
25.01.2023 | 27.01.2023 | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
Kaufen | 67.81 | 3 322 690 | 49000 | 0 | 0.03 | Link |
14.10.2022 | 18.10.2022 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 89.89 | 359 560 | 4000 | 0 | 0 | Link |
15.08.2022 | 16.08.2022 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 95.21 | 285 630 | 3000 | 0 | 0 | Link |
12.08.2022 | 16.08.2022 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 94.75 | 379 000 | 4000 | 0 | 0 | Link |
11.08.2022 | 12.08.2022 | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
Verkauf | 95.62 | 286 860 | 3000 | 0 | 0 | Link |
08.08.2022 | 10.08.2022 | Guyer Charles Greg EVP, Chief Technical Officer |
Verkauf | 96.56 | 599 155 | 6205 | 0 | 0 | Link |
08.07.2022 | 11.07.2022 | Davis George Eric EVP, Chief Legal Officer |
Verkauf | 90 | 665 820 | 7398 | 0 | 0 | Link |
25.04.2022 | 27.04.2022 | Davis George Eric EVP, Chief Legal Officer |
Kaufen | 37.46 | 99 981 | 2669 | 0 | 0 | Link |
13.04.2022 | 14.04.2022 | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
Verkauf | 82.47 | 97 315 | 1180 | 0 | 0 | Link |
14.01.2022 | 19.01.2022 | LAWLIS V BRYAN Director |
Verkauf | 87.61 | 372 343 | 4250 | 0 | 0 | Link |
14.01.2022 | 19.01.2022 | LAWLIS V BRYAN Director |
Kaufen | 37.46 | 159 205 | 4250 | 0 | 0 | Link |
13.01.2022 | 14.01.2022 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 87.86 | 439 300 | 5000 | 0 | 0 | Link |
13.01.2022 | 14.01.2022 | BIENAIME JEAN JACQUES Chief Executive Officer |
Kaufen | 37.46 | 187 300 | 5000 | 0 | 0 | Link |
12.01.2022 | 14.01.2022 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 89 | 445 000 | 5000 | 0 | 0 | Link |
12.01.2022 | 14.01.2022 | BIENAIME JEAN JACQUES Chief Executive Officer |
Kaufen | 37.46 | 187 300 | 5000 | 0 | 0 | Link |
26.10.2021 | 28.10.2021 | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
Verkauf | 73.6 | 201 590 | 2739 | 0 | 0 | Link |
10.05.2021 | 12.05.2021 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 77.29 | 657 970 | 8513 | 0 | 0 | Link |
10.05.2021 | 12.05.2021 | BIENAIME JEAN JACQUES Chief Executive Officer |
Kaufen | 26.49 | 225 509 | 8513 | 0 | 0 | Link |
07.05.2021 | 11.05.2021 | Mueller Brian EVP, Chief Financial Officer |
Verkauf | 79.5 | 533 366 | 6709 | 0 | 0 | Link |
18.03.2021 | 19.03.2021 | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
Verkauf | 77.99 | 102 011 | 1308 | 0 | 0 | Link |
29.01.2021 | 01.02.2021 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 82.67 | 688 972 | 8334 | 0 | 0 | Link |
29.01.2021 | 01.02.2021 | BIENAIME JEAN JACQUES Chief Executive Officer |
Kaufen | 26.49 | 220 768 | 8334 | 0 | 0 | Link |
28.01.2021 | 01.02.2021 | BIENAIME JEAN JACQUES Chief Executive Officer |
Verkauf | 82.91 | 690 889 | 8333 | 0 | 0 | Link |
28.01.2021 | 01.02.2021 | BIENAIME JEAN JACQUES Chief Executive Officer |
Kaufen | 26.49 | 220 741 | 8333 | 0 | 0 | Link |
Institutionen | Volumen | Aktie, % |
---|---|---|
PRIMECAP Management Company | 18414374 | 9.76 |
Vanguard Group Inc | 18050062 | 9.57 |
Blackrock Inc. | 14681644 | 7.78 |
Dodge & Cox Inc | 13994063 | 7.42 |
Capital Research Global Investors | 10774641 | 5.71 |
State Street Corporation | 6730515 | 3.57 |
Ameriprise Financial, Inc. | 5419366 | 2.87 |
Barclays PLC | 5288893 | 2.8 |
Viking Global Investors, L.P. | 4889454 | 2.59 |
Avoro Capital Advisors LLC | 4300000 | 2.28 |
Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
---|---|---|---|
Mr. Brian R. Mueller | CFO & Executive VP | 1.15M | 1974 (51 Jahr) |
Mr. George Eric Davis | Executive VP, Chief Legal Officer, General Counsel & Secretary | 1.23M | 1971 (54 Jahr) |
Ms. Erin Burkhart | Group VP & Chief Accounting Officer | N/A | 1979 (46 Jahre) |
Mr. Alexander Hardy | President, CEO & Director | N/A | 1969 (56 Jahre) |
Dr. C. Greg Guyer Ph.D. | Executive VP & CTO | 1962 (63 Jahr) | |
Dr. Kevin Eggan Ph.D. | Chief Scientific Officer & Senior VP of Research and Early Development | ||
Traci McCarty | Group Vice President of Investor Relations | ||
Ms. Humaira Serajuddin | Senior VP & Chief Marketing Officer | ||
Ms. Amy Wireman | Executive VP & Chief People Officer |
Adresse: United States, San Rafael, CA , 770 Lindaro Street - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: http://www.biomarin.com
Webseite: http://www.biomarin.com